USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALLTRANZ, INC.
Address:
2277 Thunderstick Dr
LEXINGTON, KY 40505-
Phone:
N/A
URL:
N/A
EIN:
126038943
DUNS:
178031683
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $275,525.00 2
STTR Phase I $638,344.00 2

Award List:

Transdermal Delivery of Buprenorphine Prodrugs

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$115,025.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Currently buprenorphine (BUP) is used in the treatment of opioid abuse and for pain management. It can also be used improperly and abused as an opioid. In the United States, buprenorphine is marketed in sublingual and i njectable forms. While the drug provides… More

Transdermal Cannabidiol Prodrug Delivery

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$160,500.00
Agency:
HHS
Principal Investigator:
Audra L. Stinchcomb – 410-706-2646
Abstract:
DESCRIPTION (provided by applicant): With over 8.5% of the U.S. population and 75 million people worldwide meeting the diagnostic criteria for alcohol use disorders (AUDs), alcohol abuse is among the top three preventable public health problems in the U.S.and the world. AUDs, commonly referred to as… More

Transdermal Naltrexone for Opiate Addiction and Alcoholism

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$537,779.00
Agency:
HHS
Principal Investigator:
Audra L. Stinchcomb – 410-706-2646
Research Institution:
UNIVERSITY OF MARYLAND BALT CO CAMPUS
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): According to the National Survey of Drug Use and Health (NSDUH) of 2008, 7.2 million Americans are in need of treatment for Substance-Related Disorders (SRDs), and a large proportion of those need treatment for opiate pain reliever, heroin, and alcohol addiction.… More